Why we need emergency funding for scientific research

Published



When Congress returns to Washington, America’s 560,000-strong research workforce, conducting fundamental research at public and private colleges and university campuses across the country, is counting on lawmakers to help them navigate the ongoing COVID-19 pandemic and current economic downturn. Today, many university researchers and students — not to mention, their projects — have been put off course as a result of closed facilities, reductions in occupancy and capacity, and a lack of predictable funding. More than $26 billion in emergency funding for federal research agencies is needed to help the American scientific enterprise weather this storm and come out on the other side intact.

The bipartisan “Research Investment to Spark the Economy Act,” or RISE Act, under consideration in the House of Representatives, and endorsed by the Science Coalition and numerous other higher education organizations, would authorize this much-needed funding for federal research agencies (there is currently no companion legislation in the Senate despite repeated calls from the scientific community). Without this funding, future scientific innovations and discoveries are at risk, including advancements in national security, cancer treatments, and digital agriculture, not to mention the impact to all the businesses, suppliers, and spin-off companies that are part of the university ecosystem.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.